About iTeos Therapeutics
iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients. iTeos Therapeutics leverages its deep understanding of cancer immunology and immunosuppressive pathways to design novel product candidates with the potential to fully restore the immune response against cancer. The Company’s innovative pipeline includes two clinical-stage programs targeting novel, validated immuno-oncology pathways designed with optimized pharmacologic properties for improved clinical outcomes. The first antibody product candidate, EOS-448, is a high affinity, potent, anti-TIGIT antibody with a functional Fc domain, designed to enhance the anti-tumor response through a multifaceted immune modulatory mechanism, currently progressing in multiple indications in collaboration with GSK. The Company is also advancing inupadenant, a next-generation adenosine A2A receptor antagonist tailored to overcome cancer immunosuppression into proof-of concept trials in several indications following encouraging single-agent activity in Phase 1. iTeos Therapeutics is headquartered in Cambridge, MA with a research center in Gosselies, Belgium.
|
|
|
51-200 employees
View all iTeos Therapeutics employees
|
|
Biotechnology Research
|
|
$10M–$50M
|
|
(617) 864-2500
|
|
139 Main Street, Cambridge, Massachusetts 02142, US
|
|
2011
|
|
Drug Discovery, Immunotherapy, Small Molecule Immunomodulators
|
iTeos Therapeutics Alternatives
Frequently Asked Questions about iTeos Therapeutics
Michel Detheux is the CEO of ITeos Therapeutics. To contact Michel Detheux email at [email protected] or [email protected].
The decision makers in ITeos Therapeutics are Angela James, Chad Stewart, Gabriela Rossi, etc. Click to Find ITeos Therapeutics decision makers emails.
iTeos Therapeutics headquarters is located at 139 Main Street, Cambridge, Massachusetts 02142, US.
iTeos Therapeutics generates an estimated $10M–$50M annually, based on industry analysis and publicly available market data.
You can contact iTeos Therapeutics by calling (617) 864-2500.
iTeos Therapeutics Staff Directory
Search iTeos Therapeutics Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
